tradingkey.logo

RPT-REFILE-NEKTAR THERAPEUTICS <NKTR.O>: H.C. WAINWRIGHT ADJUSTS TARGET PRICE TO $120 FROM $6.5 TO REFLECT 1-FOR-15 REVERSE STOCK SPLIT (CLARIFIES PT IS SPLIT ADJUSTED)

ReutersJun 25, 2025 9:24 AM
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI